KEY FEATURES
Full Name | Protein Kinase C Delta |
---|---|
Synonym | PKC-D; MAY1; PRKCD; SDK1; NPKC-Delta; Tyrosine-protein kinase PRKCD; Sphingosine-dependent protein kinase-1 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.15-10ng/mL |
Sensitivity | 0.06ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human PKCd in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PKCd. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PKCd and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PKCd, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PKCd. You can calculate the concentration of Human PKCd in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human PKCd ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.47 | 1.03 | 3.4 | 0.48 | 0.94 | 3.26 |
Standard deviation | 0.03 | 0.06 | 0.16 | 0.03 | 0.04 | 0.15 |
CV(%) | 5.36 | 5.9 | 4.81 | 5.81 | 4.78 | 4.6 |
RECOVERY
The recovery of Human PKCd spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 89-102 | 95 |
EDTA plasma (n=8) | 89-103 | 96 |
Cell culture media (n=8) | 92-108 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human PKCd in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with PKCd ELISA Kits
SRC ELISA Kit | publications with PKCd and SRC |
MAPK1 ELISA Kit | publications with PKCd and MAPK1 |
RHOA ELISA Kit | publications with PKCd and RHOA |
STAT1 ELISA Kit | publications with PKCd and STAT1 |
PRKCQ ELISA Kit | publications with PKCd and PRKCQ |
STAT3 ELISA Kit | publications with PKCd and STAT3 |
FYN ELISA Kit | publications with PKCd and FYN |
IRS1 ELISA Kit | publications with PKCd and IRS1 |
PIK3CA ELISA Kit | publications with PKCd and PIK3CA |
Pathways associated with PKCd ELISA Kit
AGE-RAGE Signaling Pathway In Diabetic Complications | AGE-RAGE Signaling Pathway In Diabetic Complications |
AGE/RAGE Pathway | AGE/RAGE Pathway |
Alpha 6 Beta 4 Signaling Pathway | Alpha 6 Beta 4 Signaling Pathway |
Alpha-synuclein Signaling Pathway | Alpha-synuclein Signaling Pathway |
Apoptosis Pathway | Apoptosis Pathway |
Apoptotic Cleavage Of Cellular Proteins Pathway | Apoptotic Cleavage Of Cellular Proteins Pathway |
Apoptotic Execution Phase Pathway | Apoptotic Execution Phase Pathway |
B Cell Receptor Signaling Pathway | B Cell Receptor Signaling Pathway |
Brain-Derived Neurotrophic Factor (BDNF) Signaling Pathway | Brain-Derived Neurotrophic Factor (BDNF) Signaling Pathway |
Diseases associated with PKCd ELISA Kit
Necrosis | publications with PKCd and Necrosis |
Heart Diseases | publications with PKCd and Heart Diseases |
Nervous System Diseases | publications with PKCd and Nervous System Diseases |
Disease Models, Animal | publications with PKCd and Disease Models, Animal |
Inflammation | publications with PKCd and Inflammation |
Hypertrophy | publications with PKCd and Hypertrophy |
Breast Neoplasms | publications with PKCd and Breast Neoplasms |
Cardiomyopathies | publications with PKCd and Cardiomyopathies |
Neoplasms, Experimental | publications with PKCd and Neoplasms, Experimental |
Intestinal Neoplasms | publications with PKCd and Intestinal Neoplasms |
Organs/Tissues associated with PKCd ELISA Kit
Blood | publications with PKCd and Blood |
Heart | publications with PKCd and Heart |
Vascular | publications with PKCd and Vascular |
Brain | publications with PKCd and Brain |
Nerve | publications with PKCd and Nerve |
Kidney | publications with PKCd and Kidney |
Lung | publications with PKCd and Lung |
Liver | publications with PKCd and Liver |
Skin | publications with PKCd and Skin |
Bone | publications with PKCd and Bone |